Delakas D - Search Results

1

Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors.

Androutsopoulos VP, Spyrou I, Ploumidis A, Papalampros AE, Kyriakakis M, Delakas D, Spandidos DA, Tsatsakis AM. Androutsopoulos VP, et al. Among authors: delakas d. PLoS One. 2013 Dec 16;8(12):e82487. doi: 10.1371/journal.pone.0082487. eCollection 2013. PLoS One. 2013. PMID: 24358191 Free PMC article.

2

Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.

Soulitzis N, Karyotis I, Delakas D, Spandidos DA. Soulitzis N, et al. Among authors: delakas d. Int J Oncol. 2006 Aug;29(2):305-14. Int J Oncol. 2006. PMID: 16820871

3

Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder.

Boulalas I, Zaravinos A, Delakas D, Spandidos DA. Boulalas I, et al. Among authors: delakas d. Int J Biol Markers. 2009 Jan-Mar;24(1):17-21. doi: 10.1177/172460080902400103. Int J Biol Markers. 2009. PMID: 19404918 Free article.

4

Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Papadogianni D, Soulitzis N, Delakas D, Spandidos DA. Papadogianni D, et al. Among authors: delakas d. Tumour Biol. 2014 Mar;35(3):2481-9. doi: 10.1007/s13277-013-1328-4. Epub 2013 Nov 11. Tumour Biol. 2014. PMID: 24213852

5

mRNA expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.

Pantazis E, Soulitzis N, Soufla G, Karyotis I, Delakas D, Spandidos DA. Pantazis E, et al. Among authors: delakas d. J BUON. 2011 Apr-Jun;16(2):323-30. J BUON. 2011. PMID: 21766505

6

Expression profile of Rho kinases in urinary bladder cancer.

Volanis D, Zaravinos A, Kadiyska T, Delakas D, Zoumpourlis V, Spandidos DA. Volanis D, et al. Among authors: delakas d. J BUON. 2011 Jul-Sep;16(3):511-21. J BUON. 2011. PMID: 22006759

7

Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors.

Vageli D, Kiaris H, Delakas D, Anezinis P, Cranidis A, Spandidos DA. Vageli D, et al. Among authors: delakas d. Cancer Lett. 1996 Oct 22;107(2):241-7. doi: 10.1016/0304-3835(96)04372-8. Cancer Lett. 1996. PMID: 8947520

8

Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.

Sourvinos G, Kazanis I, Delakas D, Cranidis A, Spandidos DA. Sourvinos G, et al. Among authors: delakas d. J Urol. 2001 Jan;165(1):249-52. doi: 10.1097/00005392-200101000-00073. J Urol. 2001. PMID: 11125419

9

Activation of RAS family genes in urothelial carcinoma.

Boulalas I, Zaravinos A, Karyotis I, Delakas D, Spandidos DA. Boulalas I, et al. Among authors: delakas d. J Urol. 2009 May;181(5):2312-9. doi: 10.1016/j.juro.2009.01.011. Epub 2009 Mar 19. J Urol. 2009. PMID: 19303097

10

Human lung and bladder carcinoma tumors as compared to their adjacent normal tissue have elevated AP-1 activity associated with the retinoblastoma gene promoter.

Linardopoulos S, Papadakis E, Delakas D, Theodosiou V, Cranidis A, Spandidos DA. Linardopoulos S, et al. Among authors: delakas d. Anticancer Res. 1993 Jan-Feb;13(1):257-62. Anticancer Res. 1993. PMID: 8476221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page